Fernanda F. Peres

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism.

Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism.

Journal: Frontiers in pharmacology

Published: December 04, 2024

Harmine impairs memory performance of treated rats and nontreated cagemates.

Harmine impairs memory performance of treated rats and nontreated cagemates.

Journal: Experimental and clinical psychopharmacology

Published: November 04, 2021

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?

Journal: Frontiers in pharmacology

Published: November 30, 2020

Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization.

Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization.

Journal: Biomolecules

Published: July 03, 2019

Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit.

Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit.

Journal: Neuropharmacology

Published: October 17, 2018

Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia-like behavioral abnormalities.

Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia-like behavioral abnormalities.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: July 08, 2018

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.

Journal: Frontiers in pharmacology

Published: March 06, 2018

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Journal: Frontiers in pharmacology

Published: December 23, 2017

Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.

Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.

Journal: CNS neuroscience & therapeutics

Published: December 15, 2017

A schizophrenia-like behavioral trait in the SHR model: Applying confirmatory factor analysis as a new statistical tool.

A schizophrenia-like behavioral trait in the SHR model: Applying confirmatory factor analysis as a new statistical tool.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: December 10, 2017

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.

Journal: Frontiers in pharmacology

Published: July 18, 2016

Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model.

Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model.

Journal: Schizophrenia research

Published: March 30, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026